Issue No. 03 - May/June (1999 vol. 1)
DOI Bookmark: http://doi.ieeecomputersociety.org/10.1109/5992.764208
In a world where time to market is money, the pharmaceutical industry faces special challenges. According to Eli Lilly and Company, only one in every 10,000 chemical compounds studied will complete the gauntlet of chemical analysis, testing, clinical trials, and regulatory-agency approval to actually make it to market. On average, the cost for each survivor is $500 million and 15 years of development time.
K. Schreiner, "Creativity is Key to Drug R&D," in Computing in Science & Engineering, vol. 1, no. , pp. 6-9, 1999.